跳至主要内容
临床试验/NCT05452603
NCT05452603已完成不适用

Usefulness of Wireless pH Monitoring in the Diagnosis of Gastroesophageal Reflux Disease

Hospital de Clinicas José de San Martín1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年6月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
GERD Proportion

研究概览

简要总结

Gastroesophageal reflux disease (GERD) is extremely common in our environment. Its diagnosis is complex. The Lyon Consensus defined, based on 24-hour pH monitoring, that an acid exposure time greater than 6% is definitely abnormal, less than 4% is normal, and between 4 and 6% is a gray area.

The objective of this study is to describe the change in therapeutic behavior based on the result of prolonged pH recording performed with a 96-hour wireless pH measurement capsule in patients with GERD symptoms and an acid exposure time measured by impedanciometry/pH of 24 hours in the gray area. Also, describe the therapeutic outcomes.

详细描述

Thirty consecutive patients with GERD symptoms and an acid exposure time (AET) measured by impedance measurement/pH between 4 and 6% will be included.

A 96-hour off IBP wireless pH monitoring capsule will be performed. The worst day, the average of the 4 days and the presence of 2 or more days with AET>6% and the 4 days with AET<4% will be recorded.

Patients will be categorized into GERD, reflux hypersensitivity, and functional heartburn. A treatment will be established based on these categories and the GERDq will be measured at 8 weeks of treatment.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients ≥ 18 years of age, with symptoms of gastroesophageal reflux, who have undergone a 24-hour impedance pH study without proton pump inhibitors (PPIs), whose AET is between 4 and 6% will be included consecutively. .

排除标准

  • Patients with severe comorbidities: Liver cirrhosis, oncological disease, autoimmune diseases, cognitive impairment, psychiatric diseases, bleeding diathesis or anticoagulation
  • Pregnant women
  • Patients with severe esophagitis, esophageal varices, esophageal strictures, Barrett's esophagus, anti-reflux surgery
  • Patients with history of pacemaker or defibrillator, since they can interfere with the signal.
  • Patients with nickel allergy
  • Patients that refuses to sign the informed consent.

结局指标

主要结局

GERD Proportion

时间窗: june 2021-june 2023

estimate the proportion of GERD measured by wireless pH monitoring capsule in patients in the gray area

Therapeutic response

时间窗: june 2021-june 2023

To compare the GERDq scale before and after treatment with proton pump inhibitors.

次要结局

未报告次要终点

研究者

发起方
Hospital de Clinicas José de San Martín
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Marta Piskorz

Principal investigator

Hospital de Clinicas José de San Martín

研究点 (1)

Loading locations...

相似试验